Watermark

BGB-DXP593-102

Completed

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-DXP593-102

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 65 Years

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 65 Years

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan